New-onset atrial fibrillation after percutaneous patent foramen ovale closure: a meta-analysis.
Atrial fibrillation
Occlusion
Patent foramen ovale
Percutaneous closure
Journal
Clinical research in cardiology : official journal of the German Cardiac Society
ISSN: 1861-0692
Titre abrégé: Clin Res Cardiol
Pays: Germany
ID NLM: 101264123
Informations de publication
Date de publication:
Dec 2023
Dec 2023
Historique:
received:
26
04
2023
accepted:
29
06
2023
medline:
6
12
2023
pubmed:
29
7
2023
entrez:
29
7
2023
Statut:
ppublish
Résumé
The exact incidence and predictors of new-onset atrial fibrillation (AF) after percutaneous closure of patent foramen ovale (PFO) are unknown. We sought to find post-procedural AF incidence rates and differences due to different screening strategies and devices. A systematic search was conducted in Cochrane, MEDLINE and EMBASE. Controlled trials fulfilling the inclusion criteria were included into this meta-analysis. The incidence of new-onset AF was the primary outcome. Further parameters were surveillance strategy, device type, AF treatment and neurological events. New AF was determined as early onset within one month after implantation and late thereafter. 8 controlled trials and 16 cohort studies were eligible for quantitative analysis. 7643 patients received percutaneous PFO closure after cryptogenic stroke or transient ischaemic attack, 117 with other indications, whereas 1792 patients formed the control group. Meta-analysis of controlled trials showed an AF incidence of 5.1% in the interventional and 1.6% in the conservative arm, respectively (OR 3.17, 95% CI 1.46-6.86, P = 0.03, I Percutaneous PFO closure led to higher AF post-procedural incidence compared to the conservative strategy. Heterogeneity in surveillance and follow-up strategy limited the generalizability. Registered on PROSPERO (CRD42022359945).
Sections du résumé
BACKGROUND
BACKGROUND
The exact incidence and predictors of new-onset atrial fibrillation (AF) after percutaneous closure of patent foramen ovale (PFO) are unknown.
OBJECTIVE
OBJECTIVE
We sought to find post-procedural AF incidence rates and differences due to different screening strategies and devices.
METHODS
METHODS
A systematic search was conducted in Cochrane, MEDLINE and EMBASE. Controlled trials fulfilling the inclusion criteria were included into this meta-analysis. The incidence of new-onset AF was the primary outcome. Further parameters were surveillance strategy, device type, AF treatment and neurological events. New AF was determined as early onset within one month after implantation and late thereafter.
RESULTS
RESULTS
8 controlled trials and 16 cohort studies were eligible for quantitative analysis. 7643 patients received percutaneous PFO closure after cryptogenic stroke or transient ischaemic attack, 117 with other indications, whereas 1792 patients formed the control group. Meta-analysis of controlled trials showed an AF incidence of 5.1% in the interventional and 1.6% in the conservative arm, respectively (OR 3.17, 95% CI 1.46-6.86, P = 0.03, I
CONCLUSION
CONCLUSIONS
Percutaneous PFO closure led to higher AF post-procedural incidence compared to the conservative strategy. Heterogeneity in surveillance and follow-up strategy limited the generalizability.
TRIAL REGISTRATION
BACKGROUND
Registered on PROSPERO (CRD42022359945).
Identifiants
pubmed: 37515604
doi: 10.1007/s00392-023-02263-8
pii: 10.1007/s00392-023-02263-8
pmc: PMC10697880
doi:
Types de publication
Meta-Analysis
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1824-1834Informations de copyright
© 2023. The Author(s).
Références
EuroIntervention. 2019 Jan 20;14(13):1389-1402
pubmed: 30141306
N Engl J Med. 2019 May 16;380(20):1906-1917
pubmed: 31091372
JACC Cardiovasc Interv. 2022 Nov 28;15(22):2315-2322
pubmed: 36008269
Catheter Cardiovasc Interv. 2016 Feb 15;87(3):508-14
pubmed: 26106024
J Am Coll Cardiol. 2018 May 22;71(20):2335-2342
pubmed: 29544871
BMJ. 2016 Oct 12;355:i4919
pubmed: 27733354
BMJ. 2009 Jul 21;339:b2535
pubmed: 19622551
J Interv Cardiol. 2015 Apr;28(2):190-7
pubmed: 25728716
N Engl J Med. 2018 Jun 07;378(23):2191-2201
pubmed: 29766772
Catheter Cardiovasc Interv. 2022 Apr;99(5):1551-1557
pubmed: 34773685
Eur Heart J. 2013 Nov;34(43):3362-9
pubmed: 23842846
Int J Cardiol. 2011 Jan 7;146(1):17-21
pubmed: 19487038
Lancet. 2021 Oct 23;398(10310):1498-1506
pubmed: 34469764
Catheter Cardiovasc Interv. 2009 Nov 15;74(6):889-95
pubmed: 19626689
J Am Heart Assoc. 2021 Jul 6;10(13):e021045
pubmed: 34212774
Int J Stroke. 2010 Feb;5(1):4-9
pubmed: 20088986
Ultrasound Med Biol. 2019 Aug;45(8):1882-1895
pubmed: 31104864
Clin Res Cardiol. 2022 May;111(5):583-587
pubmed: 34757488
EuroIntervention. 2012 Jul 20;8(3):345-51
pubmed: 22829510
EuroIntervention. 2019 Apr 20;14(17):1788-1790
pubmed: 30327284
J Invasive Cardiol. 2006 Aug;18(8):365-8
pubmed: 16877784
Echocardiography. 2018 Jun;35(6):834-840
pubmed: 29457261
J Interv Card Electrophysiol. 2021 Mar;60(2):165-174
pubmed: 33420712
Clin Res Cardiol. 2010 Aug;99(8):507-10
pubmed: 20352436
N Engl J Med. 2017 Sep 14;377(11):1011-1021
pubmed: 28902593
Catheter Cardiovasc Interv. 2020 Feb 15;95(3):373-374
pubmed: 32067379
Tex Heart Inst J. 2020 Aug 1;47(4):244-249
pubmed: 33472221
N Engl J Med. 2012 Mar 15;366(11):991-9
pubmed: 22417252
Lancet. 2021 Oct 23;398(10310):1507-1516
pubmed: 34469766
N Engl J Med. 2012 Jan 12;366(2):120-9
pubmed: 22236222
N Engl J Med. 2017 Sep 14;377(11):1022-1032
pubmed: 28902590
Catheter Cardiovasc Interv. 2012 Feb 1;79(2):322-30
pubmed: 21523898
BMJ. 2011 Oct 18;343:d5928
pubmed: 22008217
Int J Cardiol Heart Vasc. 2021 Nov 20;37:100919
pubmed: 34849392
Turk Kardiyol Dern Ars. 2015 Jan;43(1):38-46
pubmed: 25655849
N Engl J Med. 2013 Mar 21;368(12):1083-91
pubmed: 23514285
EuroIntervention. 2012 Oct;8(6):717-23
pubmed: 23086790
N Engl J Med. 2001 Nov 15;345(20):1444-51
pubmed: 11794192
Cardiology. 2008;111(1):47-50
pubmed: 18239392
Catheter Cardiovasc Interv. 2006 Jul;68(1):136-42; discussion 143-4
pubmed: 16755591
Cardiovasc Revasc Med. 2017 Mar;18(2):118-122
pubmed: 27847261
Circulation. 1992 Dec;86(6):1902-8
pubmed: 1451261